A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

From genomics to gene editing and cancer research, the A*STAR winners of the 2020 President’s Science and Technology Awards and Young Scientist Awards are blazing the trail in biological research.

A new method of identifying drug targets in the malaria parasite P. falciparum could find broad applications in other fields of biology.

Exploiting a mutation in a key tumor-fighting protein may provide a new opportunity to treat aggressive lung cancers.

A protein known to switch on DNA repair genes also ‘pauses’ the cell cycle in response to DNA damage, A*STAR researchers find.

A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.

Researchers at A*STAR have discovered how a class of small proteins is essential for metabolism.

Using magnets, scientists have developed an innovative pressure-based technique that represents a new frontier in needle-free drug delivery.

An international consortium gives a debilitating childhood disorder a name and a genetic cause.

In the search for new therapeutics and diagnostic tools, Sherry Aw is unraveling the biology behind movement disorders using the humble fruit fly.

A study implicates novel genetic risk factors in a rare and aggressive lymphoma affecting Asian populations.

Clinicians and scientists have discovered a rare mutation that impairs the immune system, and are using their findings to devise treatment strategies

Antibodies that recognize the SARS-CoV-2 spike protein show potential for diagnosing COVID-19.